What Is K2 / Spice? Drug Class, Schedule & Drug Test Answers
Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated September 2026
Quick answer: K2 / Spice is a Full cannabinoid-receptor agonists (indazole/indole families). Schedule I (class-wide analogue acts). Here's how the drug is classified, whether it's a narcotic/controlled substance, and what that means for testing.
What is K2 / Spice?
Drug class: Full cannabinoid-receptor agonists (indazole/indole families)
Federal schedule: Schedule I (class-wide analogue acts).
'Spice doesn't show up' is outdated: dedicated synthetic-cannabinoid strips exist on some 12-panel-plus cups, probation panels, and military programs. Coverage lags the chemistry — new analogues escape until assays update.
Is K2 / Spice a narcotic?
It is classified as a narcotic under the DEA's federal schedule. What matters more for you: Schedule I (class-wide analogue acts)..
Does it show up on drug tests?
No — it is not on the standard 5-panel; it appears only on expanded or panel-specific orders. See the full K2/Spice drug test guide for detection windows and cutoffs.
Certified labs nationwide · Results in 1–2 days
Need a test? Order online, test same-day →People also ask
Does K2 Come up on a Drug Test?
No — K2/Spice is absent from standard drug panels. Full guide →
How to Pass a Drug Test for K2?
Evidence-based ways to pass a drug test for K2/Spice — realistic timelines, what works, what backfires, and dilution flags to avoid. Full guide →
K2 / Spice Drug Test Guide: Panels, Detection Windows & More?
Complete K2/Spice drug test guide: which panels detect it, urine/hair/saliva/blood detection windows, cutoff levels and prescription verification. Full guide →
How Long Does K2/Spice Stay in Urine?
How long K2/Spice stays detectable in urine — urine, hair, saliva & blood windows explained with cutoffs. Full guide →
Do prescriptions count against me?
No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.
Sources & further reading
- SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
- DOT — 49 CFR Part 40 procedures for transportation workplace testing
- Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
- FDA — drug-of-abuse test device labeling (detection window conventions)